3 Top Guru Favorites Trading Near 52-Week Lows

Summary The Most Broadly Held Portfolio has outperformed the S&P 500 over the past decade and since inception. Three stocks in this model portfolio are trading near 52-week lows. Among GuruFocus’ ...

JNJ Bought Up Biotech Stock MeiraGTx. It Sold Procept BioRobotics.

Johnson & Johnson recently increased an investment in an embattled biotech stock, and slashed a position in a maker of surgical robotics that rocketed last year. Johnson & Johnson (ticker: JNJ...

Wall Street’s frozen market is thawing after stock rally

Traders work on the floor of the New York Stock Exchange on Wall Street in New York City. Angela Weiss | Afp | Getty Images Wall Street just pulled off its biggest IPO in four months, giving bankers h...

FDA clearance of Covid shots and treatments won’t slow with end of public health emergency

Vials and a medical syringe seen displayed in front of the Food and Drug Administration (FDA) of the United States logo. FDA finds the COVID-19 vaccine. Pavlo Gonchar | LightRocket | Getty Images The ...

Johnson And Johnson Stock Slips After Missing The Mark For Earnings

Getty Images Key takeaways Johnson and Johnson revealed lower earnings and sales numbers than expected in Q4 2022 Even before Q4 numbers were released, JNJ started falling after a slew of new stories ...

Jim Cramer picks his standout stocks in 4 bull market industries

CNBC’s Jim Cramer on Wednesday offered investors a list of bull markets he’s identified as companies report quarterly financial results. “Now that we are already one-fifth of the way...

Bed Bath & Beyond, Verizon, Lululemon and more

A pedestrian walks by a Bed Bath and Beyond store in San Francisco, California. Justin Sullivan | Getty Images Check out the companies making headlines before the bell. Verizon — Verizon shares slippe...

3M, Lyft, Verizon, Lululemon, and More Stock Market Movers

We’ve detected you are on Internet Explorer. For the best Barrons.com experience, please update to a modern browser. We’ve detected you are on Internet Explorer. For the best Barrons.com e...

J&J Reports Earnings Tuesday. What to Expect.

Johnson & Johnson CEO Joaquin Duato’s warning earlier this month that the outlook for 2023 remains uncertain is tempering investor expectations ahead of the company’s earnings reports on Tuesday. ...

Tesla, AT&T, Visa, Chevron, Microsoft, and More Stocks for Investors to Watch This Week

We’ve detected you are on Internet Explorer. For the best Barrons.com experience, please update to a modern browser. We’ve detected you are on Internet Explorer. For the best Barrons.com e...

Tanking Biotech Stocks Will Mean a Big Year for Deals. Who Could Benefit.

Nearly two years after biotechnology stocks began to tumble, executives at small and midsize companies in the space are finally accepting that share prices aren’t bouncing back anytime soon. With real...

Why Pfizer Is Pulling Back on Research Into Rare Disease, Gene Therapy

Pfizer is planning to pull back on early-stage research into treatments for rare diseases, including the development of new viral-based gene therapies, the company told employees on Thursday afternoon...

These 6 Club stocks look reasonably priced as Wall Street shuns high flyers

We’re growing increasingly worried about some richly valued companies in our portfolio, including the likes of Nvidia (NVDA) and Microsoft (MSFT). Expensive stocks remain out of favor on Wall St...

Jim Cramer predicts these 10 Dow stocks will perform well in 2023

CNBC’s Jim Cramer on Tuesday offered investors a collection of stocks that he believes will perform well this year. All of his picks are listed in the Dow Jones Industrial Average. related inves...

The 12 Best Income Investments for 2023, According to Barron’s

While it might not be a feast now for income-oriented investors, it’s a lot better than the famine that prevailed for much of the past decade. Yields on a range of bond and bond-related investments ro...

The Best Income Investing Ideas for 2023

While it might not be a feast now for income-oriented investors, it’s a lot better than the famine that prevailed for much of the past decade. Yields on a range of bond and bond-related investments ro...

Cramer’s final thoughts for the year: Making sense of multiples

The price-to-earnings multiples say recession. But the multiples said similar things in 2022. So how long can the multiples stay this low? We have all read dozens of articles about what 2023 will brin...

6 Defensive Healthcare Stocks for 2023

As investors face another uncertain year for public equities, large-cap healthcare stocks remain an attractive defensive play. They offer a shot at insulating capital from the downturn many still expe...

FDA Commissioner urges parents not to stockpile children’s flu meds

The surge in flu cases and Covid-19 infections this month, along with elevated levels of childhood respiratory syncytial virus, or RSV infections, has caused elevated demand for children’s over-...

Jim Cramer says these 7 stocks will be winners in 2023

CNBC’s Jim Cramer on Tuesday gave investors a list of stocks that he believes will perform well next year. Here is his list. Eli Lilly Humana Johnson & Johnson Caterpillar Deere TJX Companie...

Why Atlanta Tops the Hottest 2023 Real Estate Markets

Atlanta is hot. Georgia’s capital tops the National Association of Realtors’ list of markets to watch in 2023, based on 10 metrics, including housing affordability, employment conditions, and populati...

What to watch for as J&J gets ready to spin off its consumer unit

Johnson & Johnson (JNJ) is preparing next year to spin off its consumer health unit into a publicly traded company separate from its pharmaceutical and medical technology operations. Ahead of the ...

4 Advisors on Their Top Bond Buys Now

With bonds offering their juiciest yields in years, we queried some wealth management pros on where they see the best fixed-income opportunities now: David Rossmiller, Bessemer Trust: We like longer b...

Buy AbbVie Stock. The Pharma Giant Is Still Worth Owning Even as Humira Fades.

Sometimes, a single worry grows so large that it obscures all the good things happening at the same time. That’s the case with the stock of pharma giant AbbVie whose blockbuster drug Humira faces pate...

Warren Buffett And David Rolfe Agree On These 6 Stocks

Summary Both gurus have positions in Kraft Heinz, Taiwan Semiconductor, AppleAAPL , Johnson & JohnsonJNJ , VisaV and U.S. BancorpTBBK . Warren Buffett (Trades, Portfolio), the legendary investor w...

Jim Cramer says these 10 ‘old guard’ stocks are making a comeback

CNBC’s Jim Cramer on Tuesday offered investors a list of 10 companies that he believes are rising to the top as tech stocks collapse. “It’s the revenge of the old guard right now, ri...

Cano Health is a buy

Hasbro Inc: “I actually don’t even like the toy companies right now. … Let’s wait for now.” Viatris Inc: “I don’t like those guys. I do think that [Johnson &a...

Jim Cramer says to parse the Dow for recession-resilient stocks

CNBC’s Jim Cramer on Thursday advised investors on where to look for stocks that can withstand a potential economic downturn. “The Dow Jones Industrial Average is filled with relatively ch...

I don’t want to own Taiwan Semiconductor

Cerence Inc: “In a market like this, it can go to $13, $12. If you can take that level of pain, you can absolutely buy it, because it is a good company.” Matterport Inc: “It’s ...

These 8 stocks can withstand the Fed’s tightening cycle

CNBC’s Jim Cramer on Tuesday offered investors a list of stocks that he thinks will weather the market turbulence ahead. Here are his picks: Constellation Brands Eli Lilly Mondelez Kraft Kellogg...

Uber, Abiomed, Peloton, Carvana, Molson Coors and more

A traveller waits for an Uber rider at Midway International Airport on May 09, 2022 in Chicago, Illinois. Uber plans to cut spending and hiring in an attempt slow the company’s plummeting stock ...

Abiomed, Uber, SoFi, Pfizer and more

Take a look at some of the biggest movers in the premarket: Abiomed (ABMD) – Abiomed stock soared 51.6% in premarket trading after agreeing to be acquired by Johnson & Johnson (JNJ) in a nearly $1...